知镜 Cognispect · 医学文献与研究工作台

Sleep Disturbances in Chronic Kidney Disease - The CKD-REIN Cohort Study.

Stengel B, Moutard E, Metzger M, Jaussent I, Hamroun A, Laville SM, Omorou A, Fouque D, Massy ZA, Pecoits-Filho R, Frimat L, Alencar de Pinho N, Liabeuf S, CKD-REIN study investigators.
Kidney medicine · 2026-09-15 · PMID 42899186

文献摘要

Rationale & objective Insomnia and excessive daytime sleepiness (EDS) are common in patients with chronic kidney disease (CKD), but their determinants are poorly understood. We analyzed multiple factors likely to affect sleep with the aim of disentangling the contributions of CKD markers and symptoms from those of social factors, lifestyle, comorbid conditions, and drug-induced effects, with the latter 2 highly prevalent in this population. Study design Prospective cohort study. Setting & participants In total, 2,765 patients with CKD stages 2-5 not receiving dialysis (mean age, 67 ± 13 years; 66% men) from a representative sample of 40 nephrology clinics in France. Exposures Albuminuria, estimated glomerular filtration rate, CKD symptoms, lifestyle, comorbid conditions, and medications collected annually. Outcomes Insomnia and EDS ≥ 3 times/week in the past 3 months assessed with a standardized questionnaire at baseline, 1-, 3-, and 5-year follow-ups , providing 7,264 observations overall. Analytical approach Adjusted odds ratios of insomnia and EDS associated with time-updated exposures estimated with mixed effects logistic regressions. Results Baseline prevalence of reported insomnia was 22% (95% confidence interval, 21%-24%) and that of EDS, 15% (14%-16%). Based on the 7,264 observations, neither prevalence was associated with albuminuria after adjustment for age and gender. The odds ratio of EDS alone increased significantly with decreasing estimated glomerular filtration rate, 1.16 (1.05-1.28 mL/min/1.73 m 2 ) per 10 mL/min/1.73 m 2 , independent of social factors, physical activity, obesity, heart failure, and long half-life benzodiazepine use. It was no longer significant after adjustment for fatigue, which displayed a strong dose-effect relation with EDS, depression, insomnia, and sleep apnea. Insomnia prevalence increased strongly with severity of cramps, itching, and stress, independent of other determinants including female gender, heart failure, thyroid hormone use, depression, and sleep apnea. Limitations Self-reported sleep disturbances and limited longitudinal inference. Conclusions This study highlights the multifactorial nature of sleep disturbances in CKD and the potentially modifiable contribution of CKD symptoms and drug-induced effects.

在知镜精读原文来源DOI 原文

知镜提供医学文献检索、阅读笔记、人体图谱、统计绘图与研究复现工具。